A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Actinogen Medical
Cognito Therapeutics, Inc.
Eisai Inc.
Alzinova AB
Sanguine Biosciences
Cognito Therapeutics, Inc.
Samus Therapeutics, Inc.
Cognito Therapeutics, Inc.
Cognito Therapeutics, Inc.
GlaxoSmithKline
Eisai Inc.
GlaxoSmithKline
Novartis
Eisai Inc.